thioctic acid has been researched along with Dyslipidemias in 5 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niacin has been widely used as an antihyperlipidemic drug, but the flushing effect restricted its clinical application." | 7.96 | Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects. ( Cai, W; Chen, J; Jiang, Y; Jin, M; Liu, P; Pi, R; Yan, J; Yao, M, 2020) |
| "This new myo-inositol, monacolin K and lipoic acid association contains appropriate substances to contrast various etiopathogenic elements responsible for the onset of PCOS and the symptoms of hyperandrogenism and dyslipidemia related to it." | 5.20 | Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. ( Cappelli, V; De Leo, V; Di Sabatino, A; Massaro, MG; Morgante, G, 2015) |
| "Niacin has been widely used as an antihyperlipidemic drug, but the flushing effect restricted its clinical application." | 3.96 | Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects. ( Cai, W; Chen, J; Jiang, Y; Jin, M; Liu, P; Pi, R; Yan, J; Yao, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Y | 1 |
| Jin, M | 1 |
| Chen, J | 1 |
| Yan, J | 1 |
| Liu, P | 1 |
| Yao, M | 1 |
| Cai, W | 1 |
| Pi, R | 1 |
| Morgante, G | 1 |
| Cappelli, V | 1 |
| Di Sabatino, A | 1 |
| Massaro, MG | 1 |
| De Leo, V | 1 |
| Ateyya, H | 1 |
| Nader, MA | 1 |
| Attia, GM | 1 |
| El-Sherbeeny, NA | 1 |
| Poh, ZX | 1 |
| Goh, KP | 1 |
| Cummings, BP | 1 |
| Stanhope, KL | 1 |
| Graham, JL | 1 |
| Evans, JL | 1 |
| Baskin, DG | 1 |
| Griffen, SC | 1 |
| Havel, PJ | 1 |
1 review available for thioctic acid and Dyslipidemias
| Article | Year |
|---|---|
A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
Topics: Antioxidants; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Neuropath | 2009 |
1 trial available for thioctic acid and Dyslipidemias
| Article | Year |
|---|---|
Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Topics: Adult; Antioxidants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Fem | 2015 |
3 other studies available for thioctic acid and Dyslipidemias
| Article | Year |
|---|---|
Discovery of a novel niacin-lipoic acid dimer N2L attenuating atherosclerosis and dyslipidemia with non-flushing effects.
Topics: Animals; Atherosclerosis; Cell Line; Cricetulus; Dimerization; Disease Models, Animal; Drug Design; | 2020 |
Influence of alpha-lipoic acid on nicotine-induced lung and liver damage in experimental rats.
Topics: Animals; Antioxidants; Dyslipidemias; Lipid Peroxidation; Liver; Lung; Male; Nicotine; Oxidative Str | 2017 |
Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, alpha-lipoic acid.
Topics: Adiponectin; Animal Feed; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Fats; Dyslipide | 2010 |